Occult disease in reduction mammoplasties and prophylactic mastectomies.

The aim of this study was to determine the incidence of occult breast carcinoma and significant breast disease in clinically and radiologically unremarkable breast reduction specimens and prophylactic mastectomies. A retrospective search using specimen type codes was performed in the computerized hi...

Descripción completa

Detalles Bibliográficos
Publicado en:Breast Journal Vol. 26; no. 4; pp. 691 - 697
Autores principales: Nomikos, Angheliki, Husain, Ehab A., Graham, Ashley D.
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Apr2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=142907077&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 142907077
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1075122X
        ET6
      jtl: Breast Journal
      issn: 1075122X
      maglogo: Y
    pubinfo:
      dt: Apr2020
      vid: 26
      iid: 4
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        142907077
        142907077
        145816495
        142907077
        10.1111/tbj.13512
        142907077
      ppf: 691
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Occult disease in reduction mammoplasties and prophylactic mastectomies.
      aug:
        au:
          Nomikos, Angheliki
          Husain, Ehab A.
          Graham, Ashley D.
        affil: Department of Pathology, Western General Hospital, Edinburgh, UK
      sug:
        subj:
          Neoplasms, Unknown Primary
          Human
          Female
          Retrospective Design
          Archives
          Female
      ab: The aim of this study was to determine the incidence of occult breast carcinoma and significant breast disease in clinically and radiologically unremarkable breast reduction specimens and prophylactic mastectomies. A retrospective search using specimen type codes was performed in the computerized histopathology archive from April 2007 to April 2016. The pathology results of 505 patients were analyzed (782 specimens). A total of 267 patients underwent simple reduction mammoplasties (10 unilateral), 20 had bilateral prophylactic mastectomies and 218 undertook contralateral symmetrizing or prophylactic mastectomy surgery following a history of breast cancer. Overall, normal (unremarkable) breast tissue was found in 42.6% of patients (n = 215), benign tissue (nonproliferative/proliferative disease without atypia) in 51.1% (n = 258), significant disease (LCIS/proliferative disease with atypia) in 5.5% (n = 28), and malignant disease (invasive/ductal carcinoma in situ) in 0.8% (n = 4). The incidence of significant breast pathology was statistically higher (P value <.0001) in prophylactic mastectomies (12.4%) compared to reduction mammoplasties (2.3%). There was however no significant increase in the incidence of malignancy between prophylactic mastectomies (1.2%) and reduction mammoplasties (0.6%). Even though the clear majority of resected tissue in reduction mammoplasties and prophylactic mastectomies is benign, our findings support the continued need for histological examination of these specimens for occult carcinoma and precursor lesions.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N